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Protein methylationProtein lysine methylation controls gene expression and repair of deoxyribonucleic acid in the nucleus but
also occurs in the cytoplasm, where the role of this posttranslational modiﬁcation is less understood. Mem-
bers of the Smyd protein family of lysine methyltransferases are particularly abundant in the cytoplasm, with
Smyd1 and Smyd2 being most highly expressed in the heart and in skeletal muscles. Smyd1 is a crucial myo-
genic regulator with histone methyltransferase activity but also associates with myosin, which promotes sar-
comere assembly. Smyd2 methylates histones and non-histone proteins, such as the tumor suppressors, p53
and retinoblastoma protein, RB. Smyd2 has an intriguing function in the cytoplasm of skeletal myocytes,
where it methylates the chaperone Hsp90, thus promoting the interaction of a Smyd2–methyl-Hsp90 com-
plex with the N2A-domain of titin. This complex protects the sarcomeric I-band region and myocyte organi-
zation. We brieﬂy summarize some novel functions of Smyd family members, with a focus on Smyd2, and
highlight their role in striated muscles and cytoplasmic actions. We then provide experimental evidence
that Smyd2 is also important for cardiac function. In the cytoplasm of cardiomyocytes, Smyd2 was found
to associate with the sarcomeric I-band region at the titin N2A-domain. Binding to N2A occurred in vitro
and in yeast via N-terminal and extreme C-terminal regions of Smyd2. Smyd2-knockdown in zebraﬁsh
using an antisense oligonucleotide morpholino approach strongly impaired cardiac performance. We con-
clude that Smyd2 and presumably several other Smyd family members are lysine methyltransferases
which have, next to their nuclear activity, speciﬁc regulatory functions in the cytoplasm of heart and skeletal
muscle cells. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Cardiac Pathways of Dif-
ferentiation, Metabolism and Contraction.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cardiac and skeletalmuscles contain in their unitary building blocks,
the sarcomeres, a highly ordered array of cytoskeletal proteins, which
include myosin, actin, and the largest known protein titin. The mainte-
nance of these muscle proteins is a continuous process, which inten-
siﬁes during states of stress and illness. Deregulation of muscle
protein homeostasis occurswith aging and disease and directly contrib-
utes tomorbidity andmortality. Tomaintain protein homeostasis of thediomyocyte Biology: Cardiac
tion.
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l rights reserved.sarcomeric protein network, specialized quality-control mechanisms
must be in place. These include the threemajor pathways of proteolysis,
the ubiquitin–proteasome system, the autophagy-lysosomal pathway,
and the calpain system [1]. An additional element of the protein
quality-control machinery is the chaperones [2]. As regards the heart,
we are already beginning to understand important proteolytic path-
ways to mechanistic detail, but comparatively little is known about
the role of chaperones [3].
1.1. Sarcomere proteins as chaperone substrates
Molecular chaperones form a class of proteins essential for protein
homeostasis in living systems. Many chaperones are also termed heat
shock proteins (HSPs) due to their responsiveness to elevated temper-
atures. Most HSPs share fundamental biochemical properties: the abili-
ty to prevent aggregation of partially unfolded proteins and tomaintain
partially unfolded proteins in a state competent for refolding. Some
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chaperones belonging to the class of small HSPs (such as alpha-
B-crystallin, Hsp20 and Hsp27) from the cytosol to the sarcomeres has
been observed in cardiomyocytes under mechanical or biochemical
stress [4]. This translocation might exert a protective effect on cardiac
sarcomeric structure, e.g., via protection of actin, desmin and titin
[3–5]. The ubiquitous, ATP-dependent, larger HSPs, such as Hsp70 and
Hsp90, play a role in striatedmuscle, aswell. Fromworkmainly on skel-
etal muscle we know that Hsp70 and Hsp90 act in conjunction with
co-chaperones to protect myosin [6]. The co-chaperone Unc45b is
exclusively expressed in striatedmuscle and together with Hsp90 regu-
latesmyosin stability and turnover and sarcomeric A-band organization
[7,8], in a stress-dependentmanner [9]. A role for this chaperone system
is also likely in cardiomyocytes [10]. However, additional cardiac and
skeletal muscle chaperone systems must exist to help maintain the in-
tricate and elaborate protein structures of the sarcomeres.
Our recent work has established a novel mechanism whereby the
I-band region of the skeletal muscle sarcomere is protected in an
Hsp90-dependent manner [11]. Speciﬁcally, we showed that the ly-
sine methyltransferase (KMT) Smyd2 monomethylates cytoplasmic
Hsp90, thus promoting the interaction of a Smyd2–Hsp90 complex
with the N2A-domain of titin. Upon knockdown of Smyd2 and con-
comitant reduction of methylated Hsp90 in zebraﬁsh the sarcomeric
I-band region (where the N2A-domain is located) became disrupted.
Whether this mechanism is in place also in the cardiac muscle cell has
not been investigated.
1.2. Linking Hsp90 and Smyd2 methyltransferase activity to titin
protection: our rationale
The aim of the present study is twofold: 1) to provide experimental
evidence that the protection mechanism via Smyd2–methyl-Hsp90,
shown for skeletal muscle [11], is also relevant in cardiac myocytes;
and 2) to discuss the role of Smyd2 and other Smyd family members
in striated muscle, highlighting their cytoplasmic actions. We begin
with a short overview of Smyd family members and cover suggested
Smyd2 functions in more detail, before presenting new original data
about the Smyd2–methyl-Hsp90–N2A-titin link in cardiomyocytes
and relating our ﬁndings to the literature. Our experimental ap-
proach includes immunoﬂuorescence-based localization tests in
cardiac myocytes, protein–protein interaction assays, as well as a
zebraﬁsh Smyd2-knockdown model.
1.3. Smyd protein family of lysine methyltransferases, focus on Smyd2
In the Smyd (SET and MYND domain containing) protein family,
KMT capacity is provided by a (split) SET domain, originally identi-
ﬁed in Drosophila suppressor of variegation [Su(var)3-9], enhancer
of zeste [E(z)] and trithorax. A zinc ﬁnger-containing MYND domain
(after myeloid translocation protein-8, Nervy, and DEAF-1) mediates
interactions with proteins involved in transcriptional regulation and
signal transduction. The Smyd protein family has ﬁve members,
Smyd1 to 5. Smyd1, 2 and 3 are highly homologous, whereas
Smyd4 has an additional NH2-terminal extension of ∼240 amino
acids [12]. Smyd1 to 4 have in common a tetratricopeptide (TPR) like
domain at their respective COOH-termini, which is lacking in Smyd5
[12]. TPR domains are often involved in protein–protein interactions
and also in Smyd1 to 4 they mediate ligand binding, e.g., to Hsp90
[12]. Crystal structures are available for Smyd1, Smyd2, and Smyd3
[13–20].
Smyd1 is a histone methyltransferase regulating downstream
gene transcription speciﬁcally in skeletal and cardiac muscles,
where this KMT is most highly expressed [21]. The protein assumes
a critical role in early striated muscle development as a myogenic
regulator directly targeted by serum response factor and myogenin
[22]. Constitutive knockout of Smyd1 in mice disrupts cardiacdifferentiation and morphogenesis, resulting in embryonic lethality
[21]. Knockdown of Smyd1 isoforms a and b in zebraﬁsh using
morpholino antisense oligonucleotides causes severe myoﬁbrillar
disorganization and malfunction of cardiac and skeletal muscles
[23,24]. Importantly, Smyd1 also binds myosin and is localized at
theM-band region in the center of the sarcomere [24,25]. A nonsense
mutation in the Smyd1 gene is responsible for A-band disruption in the
zebraﬁsh mutant, ﬂatline (ﬂa), causing disturbed sarcomere assembly
in the heart and fast-twitch skeletal muscle [24]. Taken together,
Smyd1 is established as a striatedmuscle-speciﬁc regulator ofmyogenic
differentiation and sarcomeric A-band (myosin) assembly.
Smyd3 is best known for its role in cancer development. Knock-
down of Smyd3 in cancer cells using siRNA suppresses cell growth
suggesting that Smyd3, via its histone methyltransferase activity, pro-
motes the proliferation of cancer cells [26]. These ﬁndings have since
been conﬁrmed and extended [27,28]. Interestingly, Smyd3 also
methylates a non-histone protein in the cytoplasm, speciﬁcally, lysine
831 within the cytoplasmic portion of vascular endothelial growth
factor receptor-1 [29]. Smyd3 is expressed in various tissue types
and is also found in the heart and in skeletal muscles [26,30]. Recent-
ly, Smyd3 has been demonstrated to be required for cardiac and skel-
etal muscle development in zebraﬁsh [31], suggesting some of its
functions may be similar to those of Smyd1.
Relatively little is known yet about Smyd4 and Smyd5. Suppres-
sion of Smyd4 in humanmammary epithelial cells by siRNA promotes
cell growth, such that Smyd4 may act as a potential tumor suppressor
[32]. However, Smyd4 has also been suggested as a muscle-speciﬁc
transcriptional modulator involved in development [33]. Smyd5 is
the least studied member of this protein family. Unlike Smyd1 to 3,
and probably Smyd4, Smyd5 does not bind Hsp90 [12]. In contrast
to Smyd 1 to 4, which show more cytosolic than nuclear expression,
Smyd5 is mainly a nuclear protein [11]. In the nucleus, Smyd5 estab-
lishes histone-4 lysine-40 trimethylation as a repression checkpoint
at toll-like receptor-4-responsive promoters [34].
Smyd2 initially gained attention as a histone-3 lysine-36 (H3K36)
methyltransferase highly expressed in the heart, brain, and skeletalmus-
cle [30]. Whereas H3K36 is usually associated with active transcrip-
tion, Smyd2 participates in a Sin3A histone deacetylase repressor
complex linked to H3K36 methylation, potentially explaining why
dimethylation of H3K36 by Smyd2 can repress transcriptional activ-
ity [30]. Smyd2 also monomethylates histone-3 at lysine-4 [35].
Smyd2 methyltransferase activity and speciﬁcity for H3K4 are en-
hanced by interaction with Hsp90α—a property Smyd2 shares with
Smyd1 and Smyd3 [23,26,35]. HSP90α-dependent H3K4 methyla-
tion by Smyd2 promotes genes involved in cell cycle, chromatin
and transcription regulation [35]. In the absence of HSP90α the ac-
tivity of Smyd2 for H3K36 dimethylation is weak, hinting at H3K4
as a predominant site of methylation in vivo [35]. Unexpectedly,
then, a cardiac-speciﬁc knockout of Smyd2 in mice shows unaltered
H3K4 and H3K36 methylation patterns [36]. This Smyd2 knockout
does not impede cardiac development and reveals no basal heart
phenotype.
Smyd2 also methylates non-histone proteins, among them the
tumor suppressor p53, at lysine K370, which represses p53-dependent
transcriptional regulation [37,38]. Monomethylation via Smyd2 causes
dissociation of p53 from promoter regions of p53-target genes, in-
cluding p21 (a cyclin-dependent protein kinase important for
cell-cycle control) and mdm2 (an E3 ubiquitin ligase), increasing
their expression [37]. Evidence thus suggests that Smyd2 is involved
in apoptosis control, transcriptional inhibition, and p53-dependent
cell-cycle arrest. However, Smyd2-deﬁcient mouse hearts show
unaltered p53 protein stability and functional dysregulation of p53
by Smyd2 in vivo may be unlikely for the heart [36]. Other non-
histone targets of Smyd2 are the retinoblastoma tumor suppressor
RB, which is methylated at lysine K860 [39], and cytoplasmic Hsp90,
which is methylated at K616/K615 in mice/men [11,12]. Importantly,
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K616 [11].
In conclusion, the Smyd family represents a novel class of me-
thyltransferases with a dual function in the nucleus and cytoplasm. At
least Smyd1 to 4, which are predominantly expressed in the cytoplasm,
play a role in cardiac and skeletal muscle development or function.
2. Materials and methods
2.1. Isolation and primary culture of neonatal rat cardiomyocytes
Cardiomyocytes were isolated from neonatal (day 2) Wistar
Unilever rat hearts, essentially as described [40]. Brieﬂy, pubs were de-
capitated, hearts collected, and ventricles separated. Ventricular tissue
wasminced and digested using collagenase B (Roche). Filtered cell sus-
pensions were plated in Dulbecco's Modiﬁed Eagle Medium (DMEM)
containing 20% fetal calf serum (FCS) onto tissue culture plates. After
one hour, non-adherent cells were washed out with phosphate-
buffered saline (PBS) and myocytes were cultured at a density of
1×105 cells/cm2 onto gelatin-coated coverslips in Iscove's Modiﬁed
Dulbecco's medium (IMDM) containing 10% FCS, non-essential amino
acids (Gibco) and basic ﬁbroblast growth factor (bFGF, 100 ng/mL;
PAN Biotech). Medium was changed every other day.
2.2. Primary culture of embryonic chick cardiomyocytes
Embryonic chick cardiomyocytes were cultured as described [41],
with minor modiﬁcations. Brieﬂy, hearts from day 6 chick embryos
were minced, trypsinized, ﬁltered, and non-adherent cells were plated
on Matrigel (BD) coated 12-mm-diameter coverslips at a density of
1×106 cells/35 mm dish for staining. Transfection of Smyd2-GFP or GFP
alone was performed using Effectene (Qiagen). Approximately 3 days
after transfection, cells were prepared for immunohistochemistry.
2.3. Adult mouse heart sections
Hearts of adult C57Bl/6 mice were removed and ﬁxed with 3% PFA.
Left ventricular trabeculae were processed for parafﬁn-embedding and
cut into 5-μm sections using a sliding microtome (Leica SM2000R). For
immunohistochemistry, sections were deparafﬁnized and rehydrated.
2.4. Immunohistochemistry
Cultured cardiomyocytes were washed with PBS and ﬁxed on
coverslips with 3% paraformaldehyde (PFA) for 20 min. Cells on cov-
erslips or deparafﬁnized ventricular tissue sections were washed
twice and incubated in staining buffer (PBS/0.5% Triton X-100/3%
normal goat serum) for 20 min. Antibodies were diluted in staining
buffer and applied overnight at 4 °C (primary antibodies) or for
one hour at room temperature (secondary antibodies), with triple
washing in between. Sometimes the nuclei were stained using
Hoechst 33342 (20 min, room temperature). Procedures were
performed in the dark room. Sections or coverslips were protected
with Entellan (Merck) and analyzed using a confocal laser scanning
microscope (Nikon A1).
2.5. Mechanical manipulation and ﬂuorescence staining of isolated
cardiac myoﬁbrils
Myoﬁbrilswere isolated fromhuman donor hearts as described [42].
Brieﬂy, isolated myoﬁbrils were stretched under an inverted micro-
scope (Zeiss Axiovert 135) using a pair of micromanipulators and incu-
bated with recombinant human Smyd2 (1.5 μg protein/μL relaxing
buffer) for 30 min. After wash-out of unbound protein, myoﬁbril-
bound Smyd2 was visualized using anti-Smyd2 antibodies and Cy3-
conjugated secondary antibodies in the epiﬂuorescence mode of themicroscope (100× objective) and recorded using a CCD camera
(Sony) and Image J software. Immunoﬂuorescence images and cor-
responding phase images were recorded. Alternatively, endogenous
Smyd2 bound tomyoﬁbrils was visualized using anti-Smyd2 antibodies
and FITC-conjugated secondary antibodies.2.6. Antibodies
The primary antibodies used for immunohistochemistry were
against α-actinin (Sigma; dilution, 1:500 in PBS), GFP (Abcam; 1:300),
Smyd2 (1:50, afﬁnity-puriﬁed; Eurogentec (Belgium); made against
amino acids 1–247 of human Smyd2), titin N2A-PEVK segment
(1:200; afﬁnity-puriﬁed; Eurogentec), Hsp90 (1:200; Stressgen), and
methyl(K616)Hsp90 (1:100), kindly provided by Drs. Donlin and
Tarakhovsky [11]. For immunohistochemistry (and immunoblotting)
we also used a commercially available antibody to Smyd2 (Atlas
Sigma), with overall similar results. Secondary antibodies were Cy3,
Cy5, or FITC conjugated IgGs (1:500, Rockland).2.7. Glutathione S-transferase (GST) pulldown binding assay
Recombinant human proteins with N-terminal GST tag were gener-
ated using the vectors (Amersham) pGEX-4T1 for N2A and pGEX4T2 for
Smyd2. GST tags were removed using 5 units thrombin/mL buffer
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2, 5 mM MgCl2,
1 mM DTT). Dialyzed proteins (dialysis buffer, 50 mM Tris–HCl, pH
7.5, 150 mM NaCl, 1 mM DTT) were mixed and incubated for 90 min
on ice. The column was washed 3 times and bound proteins were visu-
alized by Western blot. Constructs were generated using the following
primer sequences:
-Titin N2A domain (human titin exons 102–109); fwd: 5′ GACA
AACCAGCTGTGGCCCC; rev: 5′CTTTCGTCGTTAGGTAC
-Full-length Smyd2; fwd: 5′ACATGAGGGCCGAGGGCC, rev: 5′TC
AGTGGCTTTCAATTTCCTG
-Smyd2 MYND domain (51–90); fwd: 5′ACCACTGCGAGTACTGC,
rev: 5′GCACTCCAGCTTGTGCATG
-Smyd2 SET domain (1–247); fwd: 5′CCGCGCCCCGCCGCC, rev: 5′
CTTCCGTTGGGTAC
-Smyd2 C-terminal domain (248–433); fwd: 5′CACTGCGAGTAC
TGC, rev: 5′TCAGTGGCTTTCAATTTCCTG
-Smyd2 11–433; fwd: 5′ACCGCTTCTGCAGCCCGGG, rev: 5′TCAG
TGGCTTTCAATTTCCTG
-Smyd2 31–433; fwd: 5′ACCTGCGGGCTCTGCAG, rev: 5′TCAGT
GGCTTTCAATTTCCTG
-Smyd2 1–423; fwd: 5′ACATGAGGGCCGAGGGCC, rev: 5′AGAAA
TATATGGATGATCTTTG
2.8. Yeast two-hybrid screen
Human titin N2A-domain (exons 102–109) was cloned into the
pGBKT7 “bait” vector (Clontech),which transformed the Saccharomyces
cerevisiae AH109 reporter strain. For an initial unbiased binding screen,
the mating partner Y187 was transformed with a complete human car-
diac cDNA library (Clontech) cloned into the pACT2 “prey” vector. Fur-
thermore, human full-length Smyd2 or deletion mutants (for primers,
see 2.7.) were cloned into the pACT2 vector in the Y187 strain. Cells
were grown for 2–3 days on synthetic dropout (SD) agar plates lacking
leucine or tryptophan. His3 reporter gene activity was monitored by
restreaking the cells on SD plates lacking histidine. Filter assays for
β-galactosidase reporter gene activity were done according to the
Clontech Matchmaker manual. Plasmids from positive clones were iso-
lated and sequenced.
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A Smyd2 atomic model was generated using PyMOL molecular
graphics system (version 1.5.0.4; Schrödinger), based on a published
human Smyd2 structure [14].
2.10. Gel ﬁltration based binding assay using puriﬁed titin and muscle
lysate
Titin was puriﬁed under native conditions as described [43], with
slight modiﬁcations. Chicken breast muscle was homogenized,
centrifuged, washed, and resuspended in 0.6 M KCl-containing ex-
traction solution. The supernatant was dialyzed against 80 mM
KCl-containing buffer, centrifuged, loaded for anion exchange chro-
matography on DEAE cellulose column (DE-52; Whatman, UK), and
bound protein was removed with 280 mM KCl-containing buffer.
The titin pool was gel-ﬁltered using Sephacryl S-500 column
(BioRad, Germany), and titin fractions were concentrated 5× by
overnight dialysis (1 MDa exclusion size) in 80 mM KCl-containing
buffer supplemented with 15% polyethylene glycol (20 K). Puriﬁed,
dialyzed titin was incubated with chicken breast muscle homoge-
nate for 15 min at 4 °C and the mix was gel-ﬁltered using SephacrylFig. 1. Localization of Smyd2 in cardiac myocytes by immunoﬂuorescence microscopy. (A) Cu
antibodies: Cy3-conjugated IgG) and α-actinin (secondary antibodies: FITC-conjugated IgG)
overexpressing Smyd2-GFP, immunostained for GFP (secondary antibodies: Cy5-conjug
higher-power magniﬁcations of the ROI boxed in the respective main panels. As a control,
stained against GFP (secondary antibodies: Cy5-conjugated IgG) and α-actinin (secondary
immunostained for sarcomere-bound endogenous Smyd2 (left panels; secondary antibod
Smyd2 protein (right panels; secondary antibodies: Cy3-conjugated IgG). Phase contrast im
(D) Schematic of the domain architecture of part of the I-band titin region. Small squares ind
within the titin N2A domain (unique sequence encoded by human titin exon 104) where Sm
methylated at lysine 616. All scale bars, 5 μm.S-500 column. Experiments were done at low-salt (150 mMNaCl) or
high-salt (600 mM NaCl). Titin-containing fractions were detected
by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE; 2–10% polyacrylamide gradients). Western blot after
12.5% SDS-PAGE was performed according to standard protocols
(ECL kit) using anti-Hsp90 antibodies (1:5000, Stressgen) and
anti-Smyd2 antibodies (1:100, Eurogentec), and was used to detect
titin-bound Hsp90 and Smyd2.
2.11. Zebraﬁsh injection procedure and analysis
Care and breeding of zebraﬁshDanio reriowere as described [44]. The
workwas carried out in accordancewith EUDirective 2010/63/EU for an-
imal experiments. Morpholino modiﬁed oligonucleotides were made
against the 5′UTR of zebraﬁsh Smyd2a (Mo-Smyd2a; 5′-ATCGCTATT
GACCTGCTGCTCGCGT-3′), the splice donor site of intron 4 of Smyd2a
(Mo-Smyd2a; 5′-AATCATCTAGACACTTACGTGCTTC-3′), and the transla-
tional start site of zebraﬁsh Smyd2b (Mo-Smyd2b; 5′-GGGATGCCT
TCTGCCTTCATCATAC-3′). A standard control oligonucleotide (Genetools)
was injected at the same concentration as a negative control (Mo-Ctrl).
Morpholinos were checked for possible cross-reactivity with other
zebraﬁsh genes, including other Smyd family members, but no cross-ltured neonatal rat cardiomyocytes immunostained for endogenous Smyd2 (secondary
; nuclei are labeled using Hoechst 33342. (B) Cultured embryonic chick cardiomyocytes
ated IgG) and α-actinin (secondary antibodies: Cy3-conjugated IgG). Insets show
the two right panels show a chick cardiomyocyte overexpressing GFP only, immuno-
antibodies: Cy3-conjugated IgG). (C) Isolated and stretched human cardiac myoﬁbrils
ies: FITC-conjugated IgG) and for Smyd2 after incubation with recombinant human
ages are shown on the bottom. A, A-band region; I, I-band region of the sarcomeres.
icate alternative splicing within the PEVK domain. Green arrowhead points at position
yd2 binds [11]. meHSP90 is the Smyd2 and N2A binding partner heat shock protein-90,
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sites on Smyd2 are not conserved between the Smyd family members.
Attempts to rescue the phenotype of Smyd2 by injection of wildtype
Smyd2a or Smyd2b mRNA together with the respective morpholino
resulted in severe early developmental defects due to toxicity. Neverthe-
less, speciﬁcity of the morphant phenotypes was validated by using
the two unrelated Smyd2a and Smyd2b morpholino types targeting
different splice sites of the speciﬁc pre-mRNA, resulting in almost in-
distinguishable knockdown phenotypes.
To inhibit pigmentation, 0.003% 1-phenyl-2-thiourea was added to
the embryo medium. Embryos were treated with deyolking buffer
(55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO3) and washed twice with
washing buffer (110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2, 10 mM
Tris–HCl, pH 8.5). For histology, embryos were ﬁxed in 4% PFA and em-
bedded in JB-4 (Polysciences). 5-μm sections were cut, dried, and
stained with hematoxylin/eosin. Western blotting after SDS-PAGE was
performed according to standard protocols (ECL kit) using anti-Hsp90
(1:5000), anti-methyl-(K616)Hsp90 (1:500) and anti-Smyd2 anti-
bodies (1:500). Terminal deoxynucleotidyl transferase dig-dUTP nick
end-labeling (TUNEL) staining for apoptotic activity was performed
using a standard kit (Roche, Switzerland). Pictures and movies were
recorded at 72 hpf and cardiac function was judged by video-based de-
tection of fractional shortening.Fig. 2. Smyd2 interacts with the titin N2A-region via an NH2-terminal segment and the extre
assays with full-length N2A-domain (encoded by human titin exons 102–109) and full-lengt
Western blot. (B) Detection of Smyd2–N2A-titin interaction by direct yeast-two-hybrid bin
N2A-titin domain as prey. Smyd2 constructs were cloned into the pACT2 vector, N2A const
were transformed. None of the Smyd2 constructs were self-activating in the assay. Middle pa
formation (M, molecular weight marker). Mating of the two haploid strains AH109 (N2A-
Smyd2 and Smyd2 mutant construct encompassing residues 11–433, indicating interact
suggesting that the Smyd2 interaction with N2A-titin occurs through Smyd2 residues 11
tetratricopeptide (TPR) domain. (D) Tertiary structure of Smyd2 (according to Ref. [14]) hi3. Results and discussion
3.1. Cytoplasmic and sarcomeric I-band localization of Smyd2 in
cardiomyocytes
To elucidate whether Smyd2 plays a role in the cardiac muscle, we
ﬁrst investigated the localization of endogenous Smyd2 in cultured neo-
natal rat cardiac myocytes (Fig. 1A). We also transfected cultured em-
bryonic chick cardiomyocytes with GFP-tagged Smyd2 to study its
localization (Fig. 1B). Immunoﬂuorescence analysis showed predomi-
nant localization of endogenous Smyd2 in the cytoplasm of neonatal
rat cardiomyocytes and only marginal presence in the nuclei, which
were demarcated byHoechst 33342 (Fig. 1A). A striated Smyd2 staining
pattern was apparent in many cells, although non-striated cytoplasmic
distribution of Smyd2 was also observed. Overexpressed Smyd2-GFP
again localized mainly to the cytoplasm (Fig. 1B). These ﬁndings are
consistent with those obtained from myoblast cell lines and skeletal
myocytes suggesting that Smyd2 is predominantly a cytoplasmic pro-
tein in striated muscle cells [11]. Whereas nuclear staining was present
to some degree, we did not see the predominantly nuclear localization
of endogenous Smyd2 reported previously in cultured neonatal rat
cardiomyocytes [36]. Possibly, nuclear localization is transient, as
suggested by shuttling between the nucleus and the cytoplasm duringme COOH-terminus. (A) Detection of Smyd2–N2A-titin interaction using GST-pulldown
h (amino acids 1–433) as well as deletion constructs of human Smyd2. Visualization by
ding assays using full-length human Smyd2 or Smyd2 deletion constructs as bait and
ructs into the pGBKT7 vector. AH109 and Y187 are yeast strains into which constructs
nels show the results of PCR analyses of haploid clones, demonstrating successful trans-
pGBKT7) and Y187 (Smyd2-pACT2) resulted in diploid yeast cells only for full-length
ion with N2A. (C) Summary of results of GST-pulldown and yeast-2-hybrid assays,
–30 and 424–433. Blue color, split SET domain, red color, MYND domain, gray color,
ghlighting segments found to interact with N2A-titin.
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members of the Smyd family [24,33,45]. In any case, Smyd2 shows pre-
dominantly cytoplasmic localization in cultured embryonic and neona-
tal vertebrate cardiomyocytes.
Higher-power images of Smyd2-overexpressing chick cardiomy-
ocytes revealed that part of the KMT pool appears in a regular striat-
ed staining pattern, associating with the sarcomeric Z-disk region
(marked by alpha-actinin) and to a minor degree with the M-band
region (Fig. 1B, insets). On closer inspection, the main staining
appeared to be on either side of the Z-disk in the I-band. No such
staining patterns were observed in cultured chick cardiomyocytes
overexpressing GFP only (Fig. 1B, right panels). We further investi-
gated the sarcomeric Smyd2 localization in adult human cardiac
myoﬁbrils, which can be isolated and stretched to increase the
I-band width [11,42]. Endogenous Smyd2 appeared again at the
I-band region, although the staining was weak and somewhat fuzzy
(Fig. 1C, left panels). M-band staining was largely, but not complete-
ly, absent. The human cardiomyoﬁbrils were also incubated with re-
combinant human Smyd2, then unbound Smyd2 was washed out
and myoﬁbril-bound Smyd2 visualized by immunoﬂuorescence. A
clear doublet of Smyd2 in the I-band region was now observed, dem-
onstrating binding on either side of the sarcomeric Z-bands (Fig. 1C,
right panels). M-band staining was not detected. Altogether, this
staining pattern of Smyd2 in myocardial samples closely resembles
the I-band staining pattern recently reported by us in skeletal
myocytes [11].
Previously we showed that Smyd2 binds in vitro and in vivo to an
I-band region of titin known as the N2A domain (Fig. 1D) [11]. In the
present study, we additionally performed an unbiased Y2H screen with
the human titin N2A-domain as bait and human cardiac cDNA library
as prey. We conﬁrmed a known binding partner of the N2A-domain,
ankyrin repeat protein-1 [46], and also detected Smyd2 as an N2A
interactor (data not shown), extending our earlier ﬁndings. The
Smyd2-binding site on the titin N2A domain has been mapped to a
unique sequence encoded by human titin exon 104 (green arrowhead
in Fig. 1D) [11].Fig. 3. Endogenous Smyd2 and methylated Hsp90 co-localize with the N2A-titin domain i
Smyd2 and α-actinin (secondary antibodies, Cy3-conjugated IgG and FITC-conjugated IgG, r
recognizing Hsp90 monomethylated at K616 (secondary antibodies, FITC-conjugated IgG). L
antibodies, Cy3-conjugated IgG) and total Hsp90 (secondary antibodies, FITC-conjugated Ig3.2. Smyd2 binds to N2A-domain via N-terminal and extreme C-terminal
segments
In order to identify the region(s) on Smyd2 that mediate the in-
teraction with titin's N2A-domain, we used full length N2A-domain
and full-length Smyd2, as well as Smyd2 deletion constructs, in GST
pulldown tests (Fig. 2A) and yeast direct binding assays (Fig. 2B).
We conﬁrmed that full-length Smyd2 interacts with N2A (Fig. 2A–
C). Among the deletion constructs, only a fragment encompassing
Smyd2 residues 11–433, lacking the ﬁrst N-terminal 10 amino
acids, interacted with N2A in vitro and in yeast. Modest binding to
N2A was observed in pulldown assays, but not in Y2H screens, for
a Smyd2 construct encompassing residues 1–423, which lacks the
extreme C-terminus. Neither the Smyd2 MYND domain (residues
51–90), nor the SET domain (residues 1–247) and the C-terminal
TPR repeat region (residues 248–433) interacted with N2A
(Fig. 2A to C). Deletion of N-terminal residues 1 to 30 also resulted
in loss of interaction. We conclude that segments at the N-terminus
(residues 11–30) and the extreme C-terminus (residues 424–433;
part of the third TPR motif) of Smyd2 are the likely mediators of
the interaction with N2A (Fig. 2C). Importantly, these segments
are surface-exposed in the published crystal structure of human
Smyd2 [14], underscoring their potential to be involved in pro-
tein–protein interactions (Fig. 2D).
3.3. Smyd2 colocalizes with K616-methylated Hsp90 and titin N2A in
cardiomyocytes
As introduced above, Smyd2 monomethylates Hsp90 at position
K616 to promote a Smyd2–methyl-Hsp90 complex at the titin N2A do-
main (Fig. 1D). The lysine methylated by Smyd2 and the nearby
sequences in Hsp90 are highly conserved from yeast to men [11]. Note
that K616 in mouse Hsp90alpha (UniProtKB Acc. #P07901) is K615
in human Hsp90alpha (Acc. #P07900) and K607 in mouse (Acc.
#P11499) and human Hsp90beta (Acc. #P08238). Whereas Smyd2
and titin N2A-domain interact no matter whether (K616-methylated)n the I-band of adult mouse cardiac sarcomeres. Upper panel: co-immunostaining of
espectively). Panel below: immunostaining against methylated Hsp90 using antibodies
ower two panels: cardiomyocyte immunostained for both titin-N2A domain (secondary
G). Arrowheads indicate Z-disk positions. Scale bar, 5 μm.
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of Smyd2 [11]. We reported that in the absence of Smyd2-mediated
Hsp90 methylation, the Smyd2–Hsp90 interaction is maintained, but
Hsp90 binding to titin is almost absent [11]. Smyd2 binds via its TPR do-
main toHsp90 [12,16] and associateswith theCOOH-terminal dimeriza-
tion domain of the chaperone [12], where also the K616methylation site
is located.
In the current study we hypothesized that endogenous Smyd2
and titin N2A-domain may colocalize in cardiomyocytes with K616-
methylated Hsp90, whereas non-methylated Hsp90 may be largely cy-
tosolic. Therefore, adult mouse heart sections were investigated by
immunoﬂuorescence microscopy using antibodies speciﬁc to Smyd2,
methyl(K616)Hsp90, all-Hsp90, and titin-N2A. As expected from the
staining pattern in human cardiomyoﬁbrils (Fig. 1C), endogenous
Smyd2 localized at the sarcomeric I-bands, with the Smyd2 bands
ﬂanking alpha-actinin striations indicative of the Z-disks (Fig. 3, top
panel). K616-methylated Hsp90 was detected in the I-band, as well,
appearing in a double-banded pattern (Fig. 3, second panel from top).
Strikingly, methyl-Hsp90 appeared exactly at the same positions (at
the same sarcomere lengths) as the titin N2A-domain (Fig. 3, second
panel frombottom). In contrast, the staining for total Hsp90was diffuse,
indicating that Hsp90 was distributed over the cytosol, although there
was also a hint of Z-disk/I-band association (Fig. 3, bottom panel).
These results demonstrate that Smyd2 and methyl-Hsp90 indeed
colocalize with titin's N2A-domain in cardiomyocytes, suggesting they
interact with one another in a complex as in skeletal muscle cells [11].
Non-methylated Hsp90 does not bind cardiac I-band titin. It is intrigu-
ing to speculate that Smyd2 functions as a co-chaperone for Hsp90 to
target N2A-titin.
Apart from K616, Smyd2 was reported to methylate another lysine in
Hsp90, K209 [12]. However, K209 methylation required the presence of
histone-3/alkaline pH, suggesting thismodiﬁcationmay occur exclusivelyFig. 4. Smyd2 and Hsp90 are detected as titin interaction partners in gel ﬁltration assays usin
titin. (A) 2–10% SDS-PAGE after DE52 anion exchange chromatography showing elution
obtained with Sephacryl 500 gel ﬁltration. (C) 2–10% SDS-PAGE of titin-containing fraction
Various proteins from muscle extract co-eluted with titin. Boxed area indicates titin fract
co-eluted with puriﬁed titin fractions. Western blots after 12.5% SDS-PAGE detect both Hsp
but not at high ionic strength (600 mM NaCl; right panels). CM, Coomassie stain; WB, Wesin the nucleus. In contrast, K616was the predominantmethylation site of
Hsp90 at neutral pHmimicking cytoplasmic conditions [12]. Thus, at least
in cardiac and skeletal muscle cells, where Smyd2 is predominantly cyto-
solic, Smyd2-mediated methylation of (cytoplasmic) Hsp90 presumably
occurs mainly or exclusively at K616.
3.4. Puriﬁed titin interacts with Smyd2 and Hsp90 from muscle extract
Binding of Smyd2 and methyl-Hsp90 to N2A-domain was dem-
onstrated previously by co-immunoprecipitation using the C2C12
skeletal myoblast cell line [11]. We aimed to provide additional evi-
dence for this interaction using an alternative binding assay. To this
end, titin was puriﬁed under native conditions from chicken breast
muscle (containing N2A-domain within the N2A-titin isoform)
using chromatographic methods (Fig. 4A and B). The puriﬁed titin
was then incubated with chicken breast muscle extract and proteins
from the extract co-eluting with titin were analyzed (Fig. 4C).
Among the proteins detected by Western blot as titin-binding part-
ners were Hsp90 and Smyd2 (Fig. 4D, left panels); the interaction
was lost under high-salt conditions (Fig. 4D, right panels). Hsp90
was also detected in a mass spectrometric screen of proteins from
the muscle extract that co-eluted with titin (data not shown). The
relatively weak intensity of the Smyd2 and Hsp90 bands compared
to the Coomassie-stained titin-band intensity (Fig. 4D, left panels)
suggests that although Smyd2 is abundantly present in the muscle
cytoplasm, only a small fraction of the Smyd2 pool associates with
titin's N2A-domain—resembling the situation with Hsp90. The ratio
of Smyd2:Hsp90 pulled out as titin-bound from the muscle extract
appeared to be nearly stoichiometric, consistent with the view that
only Smyd2-dependent methylation (of Hsp90) targets Smyd2–
Hsp90 to titin. Whether Smyd2–methyl-Hsp90 could be targeted to
titin with the help of additional mechanisms (e.g., other types ofg puriﬁed titin incubated with muscle extract. Chicken breast muscle was used to purify
proﬁle. (B) 2–10% SDS-PAGE showing native puriﬁed titin (boxed area) in fractions
s incubated with chicken breast muscle extract, following Sephacryl 500 gel ﬁltration.
ions shown at larger magniﬁcation in panel D. (D) Proteins from muscle extract that
90 and Smyd2 as titin interactors at normal ionic strength (150 mM NaCl; left panels),
tern blot.
819T. Voelkel et al. / Biochimica et Biophysica Acta 1833 (2013) 812–822posttranslational modiﬁcation), may be of interest in future work. In
summary, these results conﬁrm and extend the notion that Smyd2 and
(methylated) Hsp90 bind to titin, speciﬁcally, titin isoform that contains
N2A-domain.Fig. 5. Severe cardiac phenotype in zebraﬁsh with morpholino-mediated knockdown o
(Mo-Smyd2a) zebraﬁsh at 72 hpf. Right panels are higher-power images of the zebraﬁsh h
Mo-Smyd2a is provided as an online supplement. (B) Zebraﬁsh lysates from control and
Hsp90, and methyl-(K616)-Hsp90 (meHsp90). Data in graph are means±SEM (n=3). (C)
Mo-control hearts, measured by video imaging at 72 hpf, 84 hpf and 96 hpf. Data are me
DNA fragmentation as an indicator of apoptosis in Mo-control and Mo-Smyd2a zebraﬁsh
(white lines), indicating lack of staining (arrows).3.5. Knockdown of Smyd2 in zebraﬁsh causes a severe cardiac phenotype
To study the function of Smyd2 in vivo, we used a morpholino anti-
sense approach to knock down Smyd2 in zebraﬁsh [11]. The Smyd2f Smyd2. (A) Phenotype of morpholino-control (Mo-ctrl) and morpholino-Smyd2
eart (A, atrium; V, ventricle). A video further demonstrating the cardiac phenotype in
Smyd2a/b morpholino-treated animals analyzed by Western blot for Smyd2, total
Fractional shortening of Mo-Smyd2a and Mo-Smyd2a/b zebraﬁsh hearts compared to
ans±SEM (n=80), lines are linear regressions. (D) TUNEL staining aiming to detect
hearts at 72 hpf. Right panels show magniﬁcation of regions encompassing the heart
820 T. Voelkel et al. / Biochimica et Biophysica Acta 1833 (2013) 812–822gene is duplicated in zebraﬁsh. Smyd2a and Smyd2b are highly
expressed in somites and muscle cells at 18–72 h post fertilization
(hpf), and Smyd2a is more weakly expressed in the heart primordium
at 12 hpf [47]. We impaired the transcription of Smyd2a alone or
Smyd2a and Smyd2b paralogs together (Fig. 5). Western blot analysis
showed the repression of protein translation in Mo-Smyd2a/b ﬁsh at
72 hpf (Fig. 5B). (The Smyd2 antibody used recognized both Smyd2a
and Smyd2b paralogs, so knockdown of Smyd2a alone still revealed in-
tense signals on immunoblots.) While total Hsp90 was essentially
unchanged in Mo-Smyd2, (K616-)methylated Hsp90 was greatly re-
duced (Fig. 5B), conﬁrming our earlier ﬁndings [11]. Knocking down
Smyd2a or Smyd2a/b resulted in almost identical, severe, muscle and
heart phenotypes (Fig. 5A). The skeletal muscle phenotype was previ-
ously analyzed to ultrastructural detail and a preferential disruption of
the sarcomeric I-band region was observed, while the A-band region
appeared unaltered [11]. As regards the cardiac phenotype, Mo-
Smyd2 zebraﬁsh showedmalformation of both the atrium and ventricle
(Fig. 5A, right panels). Video analysis revealed that the cardiac defects
also included pericardial edema, elongation and thinning of the hearts,
inﬂow tract edema, and reduced heart rate (see Supplemental video).
Fractional shortening as a measure of cardiac function was reduced on
average by ~50% in Mo-Smyd2a as well as Mo-Smyd2a/b hearts com-
pared to Mo-control hearts (Fig. 5C). Taken together with our previous
ﬁndings [11], these alterations establish Smyd2 as an important regula-
tor of cardiac function.
With p53 being another target of Smyd2 methylation [37] we con-
sidered that Mo-Smyd2 zebraﬁsh hearts might show alterations in
apoptosis. However, no difference in apoptotic activity, measured by
TUNEL assay, was observed between Mo-control and Mo-Smyd2a
ﬁsh hearts (Fig. 5D). This result is consistent with the observation
that apoptosis, necrosis, and transcriptional levels of the p53 target
genes Mdm2 and p21 were unaltered in Smyd2-deﬁcient mouse
hearts [36]. Whether Smyd2-dependent methylation of other targets
affects transcriptional regulation of genes associated with proteinFig. 6. Schematic summarizing suggested actions of Smyd2 (and mtranslation, as suggested by Diehl et al. (2010) [36], was not studied
in the zebraﬁsh, but is worthwhile investigating in future work.
A role for Smyd2 in mouse heart development was previously ex-
cluded, because the mice with a cardiac-speciﬁc knockout of Smyd2
showed no basal cardiac phenotype [36]. Nevertheless, Smyd2-
deﬁcient mouse hearts could show a phenotype under conditions
of mechanical or biochemical stress or with advanced age, which
was not tested by Diehl et al. [36]. Moreover, mechanisms could be
in place in higher vertebrates which compensate for a lack of Smyd2
function. Other Smyd familymembersmight take part in such a compen-
satory response and indeed, cardiac Smyd1 transcriptswere upregulated
in the cardiac-speciﬁc Smyd2-knockout [36]. While substantial cross-
talk between Smyd family members with regard to their target methyl-
ation sites is likely, Smyd2 [11,12] and Smyd3 (in non-muscle cells) [29]
are, to our knowledge, the onlymembers so far shown tomethylate a cy-
toplasmic substrate—despite the predominantly cytosolic localization of
Smyd1 to 4 [11].
A direct comparison of Smyd1 and Smyd2, both of which are most
highly expressed in striated muscle cells, reveals rather different locali-
zation and function. Smyd1 is localized at the sarcomericM-band region
and binds to myosin [24,25], whereas Smyd2 is localized at the I-band
region and binds to titin N2A-domain ([11], this study). While both
Smyd1 and Smyd2 associate with Hsp90 [11,12,24,25], only Smyd2
has been demonstrated to methylate Hsp90 [11,12]. The Smyd2–
methyl-Hsp90–titin complex is important for I-band protection [11],
whereas the Smyd1–Hsp90 link instead has a role in protecting
M-band and A-band organization [24,25]. Smyd1 is critical for cardiac
and muscle development [21,23,48], whereas Smyd2 is not, at least in
mice [11,36]. Strikingly, in zebraﬁsh embryos the chaperone activity
of Hsp90a is required formyoﬁbrillogenesis and formaintainingmyosin
structure [49,50], and probably other sarcomeric protein structures, as
well [51]. Hsp90a together with co-chaperone Unc45b can shuttle be-
tween the A-band and the Z-disk/I-band regions under stress condi-
tions [9]. The Smyd family members might be critical regulators ofethylated Hsp90) in the cardiomyocyte. For details, see text.
821T. Voelkel et al. / Biochimica et Biophysica Acta 1833 (2013) 812–822this dynamic behavior of themaster chaperone by helping target Hsp90
to different cytoplasmic and myoﬁbrillar substrates.
3.6. Conclusions and outlook
The Smyd family of lysine methyltransferases has emerged as a reg-
ulator of striatedmuscle cell functionwith a dual role in the nucleus and
cytoplasm. Members of this family typically have histone KMT activity
and also bind to the chaperone Hsp90, through which they may help
control sarcomeric protein stability. Smyd2 is enriched in cardiac and
skeletal muscle cells, where it monomethylates cytoplasmic Hsp90 at
lysine K616 (Fig. 6). Thismodiﬁcation promotes the formation of a com-
plex between Smyd2, methyl-Hsp90 and the N2A-domain of titin, the
latter of which is part of the elastic I-band region of the skeletal (N2A)
and cardiac (N2BA) titin isoforms (Fig. 6). In the absence of Smyd2
and methylation of Hsp90, the sarcomeric I-bands are disrupted
[11], suggesting a protective effect of the Smyd2–methyl-Hsp90
complex on the titin N2A-domain. Previous [11] and current studies
(this work) demonstrate that the downregulation of Smyd2 and
methyl-Hsp90 in zebraﬁsh depresses skeletal muscle and cardiac func-
tion. Smyd2 also plays a role in the nucleus by dimethylation of histone
3 at lysine K36 and (promoted by the presence of Hsp90) monome-
thylation of histone 3 at lysine K4, which affect transcriptional activity
(Fig. 6). By methylating p53 at K370, Smyd2may also impact the activ-
ity of cell cycle regulators. These nuclear functions of Smyd2 still require
conﬁrmation in cardiac and skeletal muscle cells. We conclude that
methylation of Hsp90 by Smyd2 and perhaps also by other members
of the Smyd family importantly contributes to protein quality-control
mechanisms in the heart and in skeletal muscle by promoting complex
formation with sarcomeric proteins. It will be interesting for re-
searchers to study the recently discovered pathological modiﬁcations
in Smyd family members [52] in terms of their potential roles as modi-
ﬁer genes in muscle and heart diseases.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.09.012.
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